Syncona (LON:SYNC - Get Free Report) was up 0.8% during mid-day trading on Friday . The company traded as high as GBX 94.40 ($1.27) and last traded at GBX 94 ($1.26). Approximately 840,805 shares traded hands during mid-day trading, an increase of 9% from the average daily volume of 770,235 shares. The stock had previously closed at GBX 93.30 ($1.25).
Syncona Stock Performance
The stock has a market cap of £585.09 million, a P/E ratio of -34.67 and a beta of 0.26. The stock's fifty day simple moving average is GBX 87.65 and its 200-day simple moving average is GBX 92.20.
Syncona Company Profile
(
Get Free Report)
Syncona's purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Syncona, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Syncona wasn't on the list.
While Syncona currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
